雷帕霉素是一种大环内酯类抗生素。
本品为大环内酯类抗生素。
目的建立大环内酯类抗生素微生物限度检查方法。
Objective To establish a method for microbial limit test of macrolide antibiotics.
大环内酯类抗生素的基因工程研究进展十分迅速。
The study of gene engineering of macrolide antibiotics have made the rapid and exciting progress.
大环内酯类抗生素是治疗MP感染的有效抗生素。
Macrolides are the effective antibiotics in the treatment of MP infection.
目的：探讨大环内酯类抗生素的不良反应及用药安全性。
Objective: To study the macrolide antibiotic adverse reaction and safety of drug application.
红霉素是一类广谱大环内酯类抗生素，在临床上具有广泛的应用。
Erythromycin is a broad spectrum macrolide antibiotic and clinically used widely.
结果表明，在维港海水中，只检出较低含量的氟喹诺酮和大环内酯类抗生素；
The results showed that the concentrations of antibiotics were mainly below the limit of quantification(LOQ) in the ambient marine water of Victoria Harbour.
罗红霉素为新型大环内酯类抗生素，其体外抗菌活性类似于母体化合物红霉素。
Roxithromycin, a new macrolide antibiotic, has an antibacterial spectrum similar to that of erythromycin.
泰拉霉素是动物专用的新型大环内酯类抗生素，国内已批准用于猪呼吸系统疾病的防治。
Tulathromycin is a novel macrolide antibiotic for animals which has been approved for use in the prevention and treatment of swine respiratory disease in China.
结论：新一代大环内酯类抗生素阿奇霉素注射剂，治疗急性细菌性下呼吸道感染安全有效。
Conclusion: New generation of macrolides, azithromycin is a safe and effective antibacterial agent for the treatment of acute bacterial infections of lower respiratory tract.
大环内酯类抗生素耐药菌比例比其他族类抗生素高，在医院环境中表现出最高的耐药菌比例；
Proportion of macrolide antibiotic was higher than other antibiotics and demonstrated the highest proportion in hospitals.
第二代大环内酯类抗生素具有良好的抗菌活性和酸稳定性，但是目前耐药性问题成为当务之急。
The second generation macrolide antibiotics has the satisfactory antibacterial activity and the stability in acid. But the tolerance has been the urgent problem.
最受人重视的抗生素是庆大霉素、最主要的特征是产生氨基糖苷类抗生素和大环内酯类抗生素。
It was found that production of aminoglycoside and macrolide antibiotics by the microorganisms was most characteristic.
红霉素是糖多孢红霉菌合成的次生代谢产物，为一类广谱大环内酯类抗生素，在临床上具有广泛的应用。
Erythromycin is the secondary metabolite of Saccharopolyspora erythraea. It is a broad spectrum macrolide antibiotic and clinically used widely.
本发明提供了一种制备大环内酯类抗生素衍生物的一种中间体红霉素A - 9 -肟化合物的制备新工艺。
The present invention is new technological process of preparing erythromycin A-9-oxime compound as one intermediate of macrolide antibiotics.
持续发热可能是MP肺外并发症的相关因素之一，早期大环内酯类抗生素的应用可以减少MP肺外并发症的发生。
Persistent fever may be an important correlative factor of extra-pulmonary complications caused by mp, and early therapy of macrolide can reduce the extra-pulmonary complications.
研究表明，大环内酯类抗生素能与细菌核糖体50s亚单位的L 2 7及L 2 2蛋白质结合，抑制细菌的蛋白合成而发挥抗菌作用。
Studies showed that macrolide antibiotics exert antimicrobial effects by binding to L27 and L22 protein of the 50s subunit of bacterial ribosomes and inhibiting protein synthesis.
四环素类、大环内酯类、喹诺酮类抗生素是治疗解脲支原体感染的主要有效药物。
Tetracyclines macrolides and quinolones are the effective antibiotics in the treatment of these diseases.
四环素类、大环内酯类、喹诺酮类抗生素是治疗解脲支原体感染的主要有效药物。
Tetracyclines macrolides and quinolones are the effective antibiotics in the treatment of these diseases.
应用推荐